Soleus Capital Management, L.P. Medicenna Therapeutics Corp. Transaction History

Soleus Capital Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$3.5 - $4.56 $653,796 - $851,803	-186,799 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$3.7 - $5.97 $229,625 - $370,504	-62,061 Reduced 24.94%	186,799 $874,000
Q3 2020 Nov 13, 2020	BUY	$3.55 - $4.67 $883,453 - $1.16 Million	248,860 New	248,860 $1.03 Million

863K

Ticker MDNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,637,504
Market Cap $21.6M
Description
Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that has completed Phase IIb clinical trial for the treatment of recurrent glioblastoma, as well as...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.